Concise Prescribing Info
Listed in Dosage.
Dosage/Direction for Use
Adult: PO Chronic bronchospasm As aminophylline hydrate modified-release tab: Initial: 225-450 mg bid, increased as appropriate. IV Acute severe bronchospasm Loading: 5 mg/kg or 250-500 mg by slow inj or infusion. Maintenance: 0.5 mg/kg/hr. Max rate: 25 mg/min.
Should be taken on an empty stomach. Take on an empty stomach at least 1 hr before or 2 hr after meals.
Acute porphyria. Concomitant use w/ other xanthine derivatives.
Special Precautions
Patient w/ cardiac arrhythmia or failure, COPD, severe asthma, acute pulmonary oedema, peptic ulcer, hypo- and hyperthyroidism, glaucoma, DM, HTN, CHF, severe hypoxaemia, coronary artery disease, history of seizure, active influenza infection, acute febrile illness, sepsis. Patient undergoing influenza immunisation or in chronic alcoholism. Simultaneous admin by >1 route/preparation. Hepatic and renal impairment. Childn, elderly. Pregnancy and lactation. Monitoring Parameters Monitor heart and resp rate, arterial/capillary blood gases, and serum K levels. Monitor serum theophylline levels prior to dose adjustment.
Adverse Reactions
Nausea, vomiting, headache; hypokalaemia, hypophosphataemia, hypernatraemia, hyperglycaemia, acid/base disturbance; anxiety, insomnia, maniacal behaviour, delirium; confusion, restlessness, irritability, hyperventilation, vertigo/dizziness, tremor, convulsions; visual disturbances; palpitations, tachycardia, hypotension; abdominal pain, diarrhoea, gastro-oesophageal reflux, GI bleeding; maculo-papular rash, erythema, pruritus, urticaria, exfoliative dermatitis, rhabdomyolysis; hyperthermia, extreme thirst, transient diuresis.
Potentially Fatal: Cardiac arrhythmia, cardiorespiratory arrest, hypoxic encephalopathy.
Drug Interactions
Increased clearance w/ aminoglutethimide, carbamazepine, moracizine, phenytoin, rifampicin, sulfinpyrazone, and barbiturates. Reduced clearance w/ allopurinol, carbimazole, cimetidine, ciprofloxacin, clarithromycin, diltiazem, disulfiram, erythromycin, fluconazole, interferon, isoniazid, isoprenaline, methotrexate, mexiletine, nizatidine, norfloxacin, oxpentifylline, propafenone, propranolol, ofloxacin, thiabendazole, verapamil, viloxazine HCl and OCs. May increase steady state concentration of phenytoin.
ATC Classification
R03DA05 - aminophylline ; Belongs to the class of xanthines. Used in the systemic treatment of obstructive airway diseases.
Disclaimer: This information is independently developed by CIMS based on aminophylline from various references and is provided for your reference only. Therapeutic uses, prescribing information and product availability may vary between countries. Please refer to CIMS Product Monographs for specific and locally approved prescribing information. Although great effort has been made to ensure content accuracy, CIMS shall not be held responsible or liable for any claims or damages arising from the use or misuse of the information contained herein, its contents or omissions, or otherwise. Copyright © 2021 CIMS. All rights reserved. Powered by
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in